The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as two weeks. That may not leave enough time for the immune system to mount an effective response.
Oct 30, 2015
0
110
The first-ever comprehensive genomic analysis of the virus that causes dengue fever suggests that it may survive year-round in southern China. The study, published in the American Journal of Tropical Medicine and Hygiene, ...
Oct 12, 2015
0
24
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists.
Sep 9, 2015
0
13
Scientists at the University of California, Berkeley, have identified a key culprit responsible for the fluid loss and resulting shock that are the hallmark of severe - and potentially fatal - dengue virus infections.
Sep 9, 2015
0
113
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
Jul 28, 2015
0
40
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The findings were recently published ...
Jul 13, 2015
0
124
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue ...
Jul 2, 2015
0
70
Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.
Apr 17, 2015
0
50
(Medical Xpress)—A team of researchers working in Singapore has found that human T cells actually target dengue viral infections in the skin, which is the normal infection site. In their paper published in the journal Science ...
The worst Ebola outbreak in history is not yet over.
Mar 6, 2015
0
4
